These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15524183)

  • 1. Protease activated receptors in cardiovascular function and disease.
    Barnes JA; Singh S; Gomes AV
    Mol Cell Biochem; 2004 Aug; 263(1-2):227-39. PubMed ID: 15524183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease activated receptors in cardiovascular function and disease.
    Barnes JA; Singh S; Gomes AV
    Mol Cell Biochem; 2004 Aug; 263(1):227-39. PubMed ID: 27520681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptors: a means of converting extracellular proteolysis into intracellular signals.
    Mackie EJ; Pagel CN; Smith R; de Niese MR; Song SJ; Pike RN
    IUBMB Life; 2002 Jun; 53(6):277-81. PubMed ID: 12625364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinase-activated receptors.
    Macfarlane SR; Seatter MJ; Kanke T; Hunter GD; Plevin R
    Pharmacol Rev; 2001 Jun; 53(2):245-82. PubMed ID: 11356985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-activated receptors: contribution to physiology and disease.
    Ossovskaya VS; Bunnett NW
    Physiol Rev; 2004 Apr; 84(2):579-621. PubMed ID: 15044683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-activated receptors: protease signaling in the gastrointestinal tract.
    Amadesi S; Bunnett N
    Curr Opin Pharmacol; 2004 Dec; 4(6):551-6. PubMed ID: 15525542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, function and pathophysiology of protease activated receptors.
    Adams MN; Ramachandran R; Yau MK; Suen JY; Fairlie DP; Hollenberg MD; Hooper JD
    Pharmacol Ther; 2011 Jun; 130(3):248-82. PubMed ID: 21277892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiological actions of protease activated receptors (PARs).
    Pandya NM; Jain SM; Santani DD
    Pharmazie; 2007 Mar; 62(3):163-9. PubMed ID: 17416190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-activated receptors in neuronal development, neurodegeneration, and neuroprotection: thrombin as signaling molecule in the brain.
    Rohatgi T; Sedehizade F; Reymann KG; Reiser G
    Neuroscientist; 2004 Dec; 10(6):501-12. PubMed ID: 15534036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection.
    Luo W; Wang Y; Reiser G
    Brain Res Rev; 2007 Dec; 56(2):331-45. PubMed ID: 17915333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biological role of protease-activated receptors in angiology. The present view.
    Skórkowska K; Adamiec R
    Int Angiol; 2005 Sep; 24(3):215-20. PubMed ID: 16158029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.
    Hollenberg MD; Oikonomopoulou K; Hansen KK; Saifeddine M; Ramachandran R; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):643-51. PubMed ID: 18627296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
    Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
    Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular mediators in atherosclerosis and thrombosis: lessons from thrombin receptor knockout mice.
    Major CD; Santulli RJ; Derian CK; Andrade-Gordon P
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):931-9. PubMed ID: 12676802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-activated receptors: novel central role in modulation of gastric functions.
    Browning KN
    Neurogastroenterol Motil; 2010 Apr; 22(4):361-5. PubMed ID: 20377791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease-activated receptors, apoptosis and tumor growth.
    Borensztajn KS; Spek CA
    Pathophysiol Haemost Thromb; 2008; 36(3-4):137-47. PubMed ID: 19176987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease activated receptors: theme and variations.
    O'Brien PJ; Molino M; Kahn M; Brass LF
    Oncogene; 2001 Mar; 20(13):1570-81. PubMed ID: 11313904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-activated receptors: novel PARtners in innate immunity.
    Shpacovitch V; Feld M; Bunnett NW; Steinhoff M
    Trends Immunol; 2007 Dec; 28(12):541-50. PubMed ID: 17977790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain.
    Bunnett NW
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():39-48. PubMed ID: 16673265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-activated receptors in the musculoskeletal system.
    Mackie EJ; Loh LH; Sivagurunathan S; Uaesoontrachoon K; Yoo HJ; Wong D; Georgy SR; Pagel CN
    Int J Biochem Cell Biol; 2008; 40(6-7):1169-84. PubMed ID: 18243039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.